The global market for Bio-Therapeutic Glycoproteins was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Bio-Therapeutic Glycoproteins are bioactive compounds with carbohydrates attached to proteins. Glycan is the specific site where carbohydrate attaches to proteins and process of production is called glycosylation. Bio-therapeutic glycoproteins produced with glycan moieties that are similar to natural mammal glycans. The most common types are glycosylation O-linked and N-linked that are mainly depends on protein sequence attachment. Carbohydrates linked to proteins through either α and β linkages. Glycosylation is an important process of bio-therapeutic glycoproteins because it is critically modulated into bioactivity, stability, solubility against proteolysis, yield, clearance rate from circulation and immunogenicity. The bio-therapeutic glycoproteins mainly produced by yeast expression systems, insect cells, mammalian systems, and plant-based expression systems. In yeast expression systems, yeast is cultured chemically to scale up fermentation to an industrial level. Yeast and human share same N-glycan"s linkage. Insect cells represent an alternative system for expression of recombinant bio-therapeutic proteins. Later recombinant proteins are separated from insect cells. Mammalian Systems are used to produce complex bio-therapeutic glycoproteins. Most of the FDA approved bio-therapeutic glycoproteins derived from mammalian systems. Plant-based expression systems used for the scale-up production of glycoproteins. Among all systems, mammalian systems are well established in pharmaceuticals. Some examples of bio-therapeutic glycoproteins include tocilizumab, bevacizumab, adalimumab, etc.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bio-Therapeutic Glycoproteins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio-Therapeutic Glycoproteins.

The Bio-Therapeutic Glycoproteins market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bio-Therapeutic Glycoproteins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bio-Therapeutic Glycoproteins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Bio-Therapeutic Glycoproteins Market Report

Report Metric	Details
Report Name	Bio-Therapeutic Glycoproteins Market
CAGR	5%
Segment by Type	Antisera Cytokines Clotting Factors Hormones Enzymes Enzyme Inhibitors
Segment by Application	Oncology and Haematology Diabetes Cardiology Inflammatory Diseases Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Genentech, Hoffmann-La Roche, Genzyme Corp, Abbott Laboratories, Amgen, Biogen, Merck, GlaxoSmithKline, Novartis Pharmaceuticals Corp
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bio-Therapeutic Glycoproteins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bio-Therapeutic Glycoproteins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Bio-Therapeutic Glycoproteins Market report?

Ans: The main players in the Bio-Therapeutic Glycoproteins Market are Genentech, Hoffmann-La Roche, Genzyme Corp, Abbott Laboratories, Amgen, Biogen, Merck, GlaxoSmithKline, Novartis Pharmaceuticals Corp

What are the Application segmentation covered in the Bio-Therapeutic Glycoproteins Market report?

Ans: The Applications covered in the Bio-Therapeutic Glycoproteins Market report are Oncology and Haematology, Diabetes, Cardiology, Inflammatory Diseases, Others

What are the Type segmentation covered in the Bio-Therapeutic Glycoproteins Market report?

Ans: The Types covered in the Bio-Therapeutic Glycoproteins Market report are Antisera, Cytokines, Clotting Factors, Hormones, Enzymes, Enzyme Inhibitors

1 Bio-Therapeutic Glycoproteins Market Overview

1.1 Product Definition

1.2 Bio-Therapeutic Glycoproteins by Type

1.2.1 Global Bio-Therapeutic Glycoproteins Market Value Comparison by Type (2024 VS 2031)

1.2.2 Antisera

1.2.3 Cytokines

1.2.4 Clotting Factors

1.2.5 Hormones

1.2.6 Enzymes

1.2.7 Enzyme Inhibitors

1.3 Bio-Therapeutic Glycoproteins by Application

1.3.1 Global Bio-Therapeutic Glycoproteins Market Value by Application (2024 VS 2031)

1.3.2 Oncology and Haematology

1.3.3 Diabetes

1.3.4 Cardiology

1.3.5 Inflammatory Diseases

1.3.6 Others

1.4 Global Bio-Therapeutic Glycoproteins Market Size Estimates and Forecasts

1.4.1 Global Bio-Therapeutic Glycoproteins Revenue 2020-2031

1.4.2 Global Bio-Therapeutic Glycoproteins Sales 2020-2031

1.4.3 Global Bio-Therapeutic Glycoproteins Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Bio-Therapeutic Glycoproteins Market Competition by Manufacturers

2.1 Global Bio-Therapeutic Glycoproteins Sales Market Share by Manufacturers (2020-2025)

2.2 Global Bio-Therapeutic Glycoproteins Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Bio-Therapeutic Glycoproteins Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Bio-Therapeutic Glycoproteins, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Bio-Therapeutic Glycoproteins, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Bio-Therapeutic Glycoproteins, Product Type & Application

2.7 Global Key Manufacturers of Bio-Therapeutic Glycoproteins, Date of Enter into This Industry

2.8 Global Bio-Therapeutic Glycoproteins Market Competitive Situation and Trends

2.8.1 Global Bio-Therapeutic Glycoproteins Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Bio-Therapeutic Glycoproteins Players Market Share by Revenue

2.8.3 Global Bio-Therapeutic Glycoproteins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Bio-Therapeutic Glycoproteins Market Scenario by Region

3.1 Global Bio-Therapeutic Glycoproteins Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Bio-Therapeutic Glycoproteins Sales by Region: 2020-2031

3.2.1 Global Bio-Therapeutic Glycoproteins Sales by Region: 2020-2025

3.2.2 Global Bio-Therapeutic Glycoproteins Sales by Region: 2026-2031

3.3 Global Bio-Therapeutic Glycoproteins Revenue by Region: 2020-2031

3.3.1 Global Bio-Therapeutic Glycoproteins Revenue by Region: 2020-2025

3.3.2 Global Bio-Therapeutic Glycoproteins Revenue by Region: 2026-2031

3.4 North America Bio-Therapeutic Glycoproteins Market Facts & Figures by Country

3.4.1 North America Bio-Therapeutic Glycoproteins Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Bio-Therapeutic Glycoproteins Sales by Country (2020-2031)

3.4.3 North America Bio-Therapeutic Glycoproteins Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Bio-Therapeutic Glycoproteins Market Facts & Figures by Country

3.5.1 Europe Bio-Therapeutic Glycoproteins Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Bio-Therapeutic Glycoproteins Sales by Country (2020-2031)

3.5.3 Europe Bio-Therapeutic Glycoproteins Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Bio-Therapeutic Glycoproteins Market Facts & Figures by Region

3.6.1 Asia Pacific Bio-Therapeutic Glycoproteins Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Bio-Therapeutic Glycoproteins Sales by Region (2020-2031)

3.6.3 Asia Pacific Bio-Therapeutic Glycoproteins Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Bio-Therapeutic Glycoproteins Market Facts & Figures by Country

3.7.1 Latin America Bio-Therapeutic Glycoproteins Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Bio-Therapeutic Glycoproteins Sales by Country (2020-2031)

3.7.3 Latin America Bio-Therapeutic Glycoproteins Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Bio-Therapeutic Glycoproteins Market Facts & Figures by Country

3.8.1 Middle East and Africa Bio-Therapeutic Glycoproteins Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Bio-Therapeutic Glycoproteins Sales by Country (2020-2031)

3.8.3 Middle East and Africa Bio-Therapeutic Glycoproteins Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Bio-Therapeutic Glycoproteins Sales by Type (2020-2031)

4.1.1 Global Bio-Therapeutic Glycoproteins Sales by Type (2020-2025)

4.1.2 Global Bio-Therapeutic Glycoproteins Sales by Type (2026-2031)

4.1.3 Global Bio-Therapeutic Glycoproteins Sales Market Share by Type (2020-2031)

4.2 Global Bio-Therapeutic Glycoproteins Revenue by Type (2020-2031)

4.2.1 Global Bio-Therapeutic Glycoproteins Revenue by Type (2020-2025)

4.2.2 Global Bio-Therapeutic Glycoproteins Revenue by Type (2026-2031)

4.2.3 Global Bio-Therapeutic Glycoproteins Revenue Market Share by Type (2020-2031)

4.3 Global Bio-Therapeutic Glycoproteins Price by Type (2020-2031)

5 Segment by Application

5.1 Global Bio-Therapeutic Glycoproteins Sales by Application (2020-2031)

5.1.1 Global Bio-Therapeutic Glycoproteins Sales by Application (2020-2025)

5.1.2 Global Bio-Therapeutic Glycoproteins Sales by Application (2026-2031)

5.1.3 Global Bio-Therapeutic Glycoproteins Sales Market Share by Application (2020-2031)

5.2 Global Bio-Therapeutic Glycoproteins Revenue by Application (2020-2031)

5.2.1 Global Bio-Therapeutic Glycoproteins Revenue by Application (2020-2025)

5.2.2 Global Bio-Therapeutic Glycoproteins Revenue by Application (2026-2031)

5.2.3 Global Bio-Therapeutic Glycoproteins Revenue Market Share by Application (2020-2031)

5.3 Global Bio-Therapeutic Glycoproteins Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Genentech

6.1.1 Genentech Company Information

6.1.2 Genentech Description and Business Overview

6.1.3 Genentech Bio-Therapeutic Glycoproteins Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Genentech Bio-Therapeutic Glycoproteins Product Portfolio

6.1.5 Genentech Recent Developments/Updates

6.2 Hoffmann-La Roche

6.2.1 Hoffmann-La Roche Company Information

6.2.2 Hoffmann-La Roche Description and Business Overview

6.2.3 Hoffmann-La Roche Bio-Therapeutic Glycoproteins Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Hoffmann-La Roche Bio-Therapeutic Glycoproteins Product Portfolio

6.2.5 Hoffmann-La Roche Recent Developments/Updates

6.3 Genzyme Corp

6.3.1 Genzyme Corp Company Information

6.3.2 Genzyme Corp Description and Business Overview

6.3.3 Genzyme Corp Bio-Therapeutic Glycoproteins Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Genzyme Corp Bio-Therapeutic Glycoproteins Product Portfolio

6.3.5 Genzyme Corp Recent Developments/Updates

6.4 Abbott Laboratories

6.4.1 Abbott Laboratories Company Information

6.4.2 Abbott Laboratories Description and Business Overview

6.4.3 Abbott Laboratories Bio-Therapeutic Glycoproteins Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Abbott Laboratories Bio-Therapeutic Glycoproteins Product Portfolio

6.4.5 Abbott Laboratories Recent Developments/Updates

6.5 Amgen

6.5.1 Amgen Company Information

6.5.2 Amgen Description and Business Overview

6.5.3 Amgen Bio-Therapeutic Glycoproteins Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Amgen Bio-Therapeutic Glycoproteins Product Portfolio

6.5.5 Amgen Recent Developments/Updates

6.6 Biogen

6.6.1 Biogen Company Information

6.6.2 Biogen Description and Business Overview

6.6.3 Biogen Bio-Therapeutic Glycoproteins Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Biogen Bio-Therapeutic Glycoproteins Product Portfolio

6.6.5 Biogen Recent Developments/Updates

6.7 Merck

6.7.1 Merck Company Information

6.7.2 Merck Description and Business Overview

6.7.3 Merck Bio-Therapeutic Glycoproteins Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Merck Bio-Therapeutic Glycoproteins Product Portfolio

6.7.5 Merck Recent Developments/Updates

6.8 GlaxoSmithKline

6.8.1 GlaxoSmithKline Company Information

6.8.2 GlaxoSmithKline Description and Business Overview

6.8.3 GlaxoSmithKline Bio-Therapeutic Glycoproteins Sales, Revenue and Gross Margin (2020-2025)

6.8.4 GlaxoSmithKline Bio-Therapeutic Glycoproteins Product Portfolio

6.8.5 GlaxoSmithKline Recent Developments/Updates

6.9 Novartis Pharmaceuticals Corp

6.9.1 Novartis Pharmaceuticals Corp Company Information

6.9.2 Novartis Pharmaceuticals Corp Description and Business Overview

6.9.3 Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Product Portfolio

6.9.5 Novartis Pharmaceuticals Corp Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Bio-Therapeutic Glycoproteins Industry Chain Analysis

7.2 Bio-Therapeutic Glycoproteins Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Bio-Therapeutic Glycoproteins Production Mode & Process Analysis

7.4 Bio-Therapeutic Glycoproteins Sales and Marketing

7.4.1 Bio-Therapeutic Glycoproteins Sales Channels

7.4.2 Bio-Therapeutic Glycoproteins Distributors

7.5 Bio-Therapeutic Glycoproteins Customer Analysis

8 Bio-Therapeutic Glycoproteins Market Dynamics

8.1 Bio-Therapeutic Glycoproteins Industry Trends

8.2 Bio-Therapeutic Glycoproteins Market Drivers

8.3 Bio-Therapeutic Glycoproteins Market Challenges

8.4 Bio-Therapeutic Glycoproteins Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Novartis Pharmaceuticals Corp

List of Tables

Table 1. Global Bio-Therapeutic Glycoproteins Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Bio-Therapeutic Glycoproteins Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Bio-Therapeutic Glycoproteins Market Competitive Situation by Manufacturers in 2024

Table 4. Global Bio-Therapeutic Glycoproteins Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Bio-Therapeutic Glycoproteins Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Bio-Therapeutic Glycoproteins Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Bio-Therapeutic Glycoproteins Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Bio-Therapeutic Glycoproteins Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Bio-Therapeutic Glycoproteins, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Bio-Therapeutic Glycoproteins, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Bio-Therapeutic Glycoproteins, Product Type & Application

Table 12. Global Key Manufacturers of Bio-Therapeutic Glycoproteins, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Bio-Therapeutic Glycoproteins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio-Therapeutic Glycoproteins as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Bio-Therapeutic Glycoproteins Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Bio-Therapeutic Glycoproteins Sales by Region (2020-2025) & (K Units)

Table 18. Global Bio-Therapeutic Glycoproteins Sales Market Share by Region (2020-2025)

Table 19. Global Bio-Therapeutic Glycoproteins Sales by Region (2026-2031) & (K Units)

Table 20. Global Bio-Therapeutic Glycoproteins Sales Market Share by Region (2026-2031)

Table 21. Global Bio-Therapeutic Glycoproteins Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Bio-Therapeutic Glycoproteins Revenue Market Share by Region (2020-2025)

Table 23. Global Bio-Therapeutic Glycoproteins Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Bio-Therapeutic Glycoproteins Revenue Market Share by Region (2026-2031)

Table 25. North America Bio-Therapeutic Glycoproteins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Bio-Therapeutic Glycoproteins Sales by Country (2020-2025) & (K Units)

Table 27. North America Bio-Therapeutic Glycoproteins Sales by Country (2026-2031) & (K Units)

Table 28. North America Bio-Therapeutic Glycoproteins Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Bio-Therapeutic Glycoproteins Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Bio-Therapeutic Glycoproteins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Bio-Therapeutic Glycoproteins Sales by Country (2020-2025) & (K Units)

Table 32. Europe Bio-Therapeutic Glycoproteins Sales by Country (2026-2031) & (K Units)

Table 33. Europe Bio-Therapeutic Glycoproteins Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Bio-Therapeutic Glycoproteins Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Bio-Therapeutic Glycoproteins Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Bio-Therapeutic Glycoproteins Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Bio-Therapeutic Glycoproteins Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Bio-Therapeutic Glycoproteins Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Bio-Therapeutic Glycoproteins Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Bio-Therapeutic Glycoproteins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Bio-Therapeutic Glycoproteins Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Bio-Therapeutic Glycoproteins Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Bio-Therapeutic Glycoproteins Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Bio-Therapeutic Glycoproteins Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Bio-Therapeutic Glycoproteins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Bio-Therapeutic Glycoproteins Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Bio-Therapeutic Glycoproteins Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Bio-Therapeutic Glycoproteins Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Bio-Therapeutic Glycoproteins Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Bio-Therapeutic Glycoproteins Sales (K Units) by Type (2020-2025)

Table 51. Global Bio-Therapeutic Glycoproteins Sales (K Units) by Type (2026-2031)

Table 52. Global Bio-Therapeutic Glycoproteins Sales Market Share by Type (2020-2025)

Table 53. Global Bio-Therapeutic Glycoproteins Sales Market Share by Type (2026-2031)

Table 54. Global Bio-Therapeutic Glycoproteins Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Bio-Therapeutic Glycoproteins Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Bio-Therapeutic Glycoproteins Revenue Market Share by Type (2020-2025)

Table 57. Global Bio-Therapeutic Glycoproteins Revenue Market Share by Type (2026-2031)

Table 58. Global Bio-Therapeutic Glycoproteins Price (USD/Unit) by Type (2020-2025)

Table 59. Global Bio-Therapeutic Glycoproteins Price (USD/Unit) by Type (2026-2031)

Table 60. Global Bio-Therapeutic Glycoproteins Sales (K Units) by Application (2020-2025)

Table 61. Global Bio-Therapeutic Glycoproteins Sales (K Units) by Application (2026-2031)

Table 62. Global Bio-Therapeutic Glycoproteins Sales Market Share by Application (2020-2025)

Table 63. Global Bio-Therapeutic Glycoproteins Sales Market Share by Application (2026-2031)

Table 64. Global Bio-Therapeutic Glycoproteins Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Bio-Therapeutic Glycoproteins Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Bio-Therapeutic Glycoproteins Revenue Market Share by Application (2020-2025)

Table 67. Global Bio-Therapeutic Glycoproteins Revenue Market Share by Application (2026-2031)

Table 68. Global Bio-Therapeutic Glycoproteins Price (USD/Unit) by Application (2020-2025)

Table 69. Global Bio-Therapeutic Glycoproteins Price (USD/Unit) by Application (2026-2031)

Table 70. Genentech Company Information

Table 71. Genentech Description and Business Overview

Table 72. Genentech Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Genentech Bio-Therapeutic Glycoproteins Product

Table 74. Genentech Recent Developments/Updates

Table 75. Hoffmann-La Roche Company Information

Table 76. Hoffmann-La Roche Description and Business Overview

Table 77. Hoffmann-La Roche Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Hoffmann-La Roche Bio-Therapeutic Glycoproteins Product

Table 79. Hoffmann-La Roche Recent Developments/Updates

Table 80. Genzyme Corp Company Information

Table 81. Genzyme Corp Description and Business Overview

Table 82. Genzyme Corp Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Genzyme Corp Bio-Therapeutic Glycoproteins Product

Table 84. Genzyme Corp Recent Developments/Updates

Table 85. Abbott Laboratories Company Information

Table 86. Abbott Laboratories Description and Business Overview

Table 87. Abbott Laboratories Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Abbott Laboratories Bio-Therapeutic Glycoproteins Product

Table 89. Abbott Laboratories Recent Developments/Updates

Table 90. Amgen Company Information

Table 91. Amgen Description and Business Overview

Table 92. Amgen Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Amgen Bio-Therapeutic Glycoproteins Product

Table 94. Amgen Recent Developments/Updates

Table 95. Biogen Company Information

Table 96. Biogen Description and Business Overview

Table 97. Biogen Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Biogen Bio-Therapeutic Glycoproteins Product

Table 99. Biogen Recent Developments/Updates

Table 100. Merck Company Information

Table 101. Merck Description and Business Overview

Table 102. Merck Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Merck Bio-Therapeutic Glycoproteins Product

Table 104. Merck Recent Developments/Updates

Table 105. GlaxoSmithKline Company Information

Table 106. GlaxoSmithKline Description and Business Overview

Table 107. GlaxoSmithKline Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. GlaxoSmithKline Bio-Therapeutic Glycoproteins Product

Table 109. GlaxoSmithKline Recent Developments/Updates

Table 110. Novartis Pharmaceuticals Corp Company Information

Table 111. Novartis Pharmaceuticals Corp Description and Business Overview

Table 112. Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Product

Table 114. Novartis Pharmaceuticals Corp Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Bio-Therapeutic Glycoproteins Distributors List

Table 118. Bio-Therapeutic Glycoproteins Customers List

Table 119. Bio-Therapeutic Glycoproteins Market Trends

Table 120. Bio-Therapeutic Glycoproteins Market Drivers

Table 121. Bio-Therapeutic Glycoproteins Market Challenges

Table 122. Bio-Therapeutic Glycoproteins Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Bio-Therapeutic Glycoproteins

Figure 2. Global Bio-Therapeutic Glycoproteins Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Bio-Therapeutic Glycoproteins Market Share by Type: 2024 & 2031

Figure 4. Antisera Product Picture

Figure 5. Cytokines Product Picture

Figure 6. Clotting Factors Product Picture

Figure 7. Hormones Product Picture

Figure 8. Enzymes Product Picture

Figure 9. Enzyme Inhibitors Product Picture

Figure 10. Global Bio-Therapeutic Glycoproteins Market Value by Application (2020-2031) & (US$ Million)

Figure 11. Global Bio-Therapeutic Glycoproteins Market Share by Application: 2024 & 2031

Figure 12. Oncology and Haematology

Figure 13. Diabetes

Figure 14. Cardiology

Figure 15. Inflammatory Diseases

Figure 16. Others

Figure 17. Global Bio-Therapeutic Glycoproteins Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Bio-Therapeutic Glycoproteins Market Size (2020-2031) & (US$ Million)

Figure 19. Global Bio-Therapeutic Glycoproteins Sales (2020-2031) & (K Units)

Figure 20. Global Bio-Therapeutic Glycoproteins Average Price (USD/Unit) & (2020-2031)

Figure 21. Bio-Therapeutic Glycoproteins Report Years Considered

Figure 22. Bio-Therapeutic Glycoproteins Sales Share by Manufacturers in 2024

Figure 23. Global Bio-Therapeutic Glycoproteins Revenue Share by Manufacturers in 2024

Figure 24. Global 5 and 10 Largest Bio-Therapeutic Glycoproteins Players: Market Share by Revenue in Bio-Therapeutic Glycoproteins in 2024

Figure 25. Bio-Therapeutic Glycoproteins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 26. Global Bio-Therapeutic Glycoproteins Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 27. North America Bio-Therapeutic Glycoproteins Sales Market Share by Country (2020-2031)

Figure 28. North America Bio-Therapeutic Glycoproteins Revenue Market Share by Country (2020-2031)

Figure 29. U.S. Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Canada Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Europe Bio-Therapeutic Glycoproteins Sales Market Share by Country (2020-2031)

Figure 32. Europe Bio-Therapeutic Glycoproteins Revenue Market Share by Country (2020-2031)

Figure 33. Germany Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. France Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. U.K. Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Italy Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Russia Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Asia Pacific Bio-Therapeutic Glycoproteins Sales Market Share by Region (2020-2031)

Figure 39. Asia Pacific Bio-Therapeutic Glycoproteins Revenue Market Share by Region (2020-2031)

Figure 40. China Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Japan Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. South Korea Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. India Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Australia Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Taiwan Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Indonesia Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Thailand Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Malaysia Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Philippines Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Latin America Bio-Therapeutic Glycoproteins Sales Market Share by Country (2020-2031)

Figure 51. Latin America Bio-Therapeutic Glycoproteins Revenue Market Share by Country (2020-2031)

Figure 52. Mexico Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Brazil Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Argentina Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Middle East and Africa Bio-Therapeutic Glycoproteins Sales Market Share by Country (2020-2031)

Figure 56. Middle East and Africa Bio-Therapeutic Glycoproteins Revenue Market Share by Country (2020-2031)

Figure 57. Turkey Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. Saudi Arabia Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 59. U.A.E Bio-Therapeutic Glycoproteins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 60. Global Sales Market Share of Bio-Therapeutic Glycoproteins by Type (2020-2031)

Figure 61. Global Revenue Market Share of Bio-Therapeutic Glycoproteins by Type (2020-2031)

Figure 62. Global Bio-Therapeutic Glycoproteins Price (USD/Unit) by Type (2020-2031)

Figure 63. Global Sales Market Share of Bio-Therapeutic Glycoproteins by Application (2020-2031)

Figure 64. Global Revenue Market Share of Bio-Therapeutic Glycoproteins by Application (2020-2031)

Figure 65. Global Bio-Therapeutic Glycoproteins Price (USD/Unit) by Application (2020-2031)

Figure 66. Bio-Therapeutic Glycoproteins Value Chain

Figure 67. Channels of Distribution (Direct Vs Distribution)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions